eComment. Septal reduction therapy for hypertrophic cardiomyopathy: the need of experienced centres

被引：0
|
作者：
Garcia-Villarreal, Ovidio A. [1 ]
机构：
[1] Hosp Cardiovasc Dis 34, IMSS, Dept Cardiac Surg, Monterrey, Mexico
来源：
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY | 2013年 / 16卷 / 01期
关键词：
D O I：
10.1093/icvts/ivs468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [11] Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    Desai, Milind Y.
    Owens, Anjali
    Geske, Jeffrey B.
    Wolski, Kathy
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Cremer, Paul C.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Li, Wanying
    Sterling, Lulu
    Lampl, Kathy
    Edelberg, Jay M.
    Sehnert, Amy J.
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) : 95 - 108
  • [12] Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
    Maekawa, Yuichiro
    Akita, Keitaro
    Takanashi, Shuichiro
    CIRCULATION JOURNAL, 2018, 82 (08) : 1977 - 1984
  • [13] COSTS OF SEPTAL REDUCTION THERAPY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A US CLAIMS ANALYSIS
    Butzner, M.
    Sarocco, P.
    Maron, M.
    Rowin, E.
    Teng, C. C.
    Stanek, E.
    Tan, H.
    Robertson, L.
    VALUE IN HEALTH, 2021, 24 : S73 - S73
  • [14] IMPACT OF PULMONARY HYPERTENSION ON SEPTAL REDUCTION THERAPY OUTCOMES FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Isath, Ameesh
    Lanier, Gregg M.
    Spielvogel, David
    Malekan, Ramin
    Steinmetz, Carolyn
    Semaan, Rosa
    Fishkin, Tzvi
    Panza, Julio A.
    Naidu, Srihari S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 549 - 549
  • [15] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy
    Kuhn, HJ
    CIRCULATION, 1998, 97 (07) : 708 - 709
  • [16] Predictors of need for permanent pacemaker after non-surgical septal reduction therapy (NSRT) with ethanol for hypertrophic obstructive cardiomyopathy
    Chang, SM
    Nagueh, S
    Spencer, WH
    Lakkis, NM
    CIRCULATION, 2002, 106 (19) : 654 - 655
  • [17] Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy
    Crossen, Karl
    Jones, Marsha
    Erikson, Christopher
    HEART RHYTHM, 2016, 13 (09) : 1885 - 1890
  • [18] Alcohol septal ablation in hypertrophic obstructive cardiomyopathy - The need for a registry
    Spencer, WH
    Roberts, R
    CIRCULATION, 2000, 102 (06) : 600 - 601
  • [19] Left ventricular remodelling after nonsurgical septal reduction therapy for obstructive hypertrophic cardiomyopathy
    Nagueh, SF
    Spencer, WH
    Lakkis, NM
    Zoghbi, WA
    Kleiman, NS
    Killip, DM
    Roberts, R
    Quinones, MA
    CIRCULATION, 1997, 96 (08) : 3277 - 3277
  • [20] Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy br
    Butzner, Michael
    Maron, Martin S.
    Sarocco, Phil
    Teng, Chia-Chen
    Stanek, Eric
    Tan, Hiangkiat
    Robertson, Laura A.
    JOURNAL OF INVASIVE CARDIOLOGY, 2022, 34 (12): : E866 - E872
12345